New Hampshire Hospital Association
Real-Time Legislative Update

Friday, April 20, 2018 12:03 PM


BillTitle & Upcoming MeetingsSponsorCategoriesStatusOur Position
HB 1418 (new Title) Relative Establishing A Commission to Study Greater Transparency In Pharmaceutical Costs and Drug Rebate Programs.

Rep. Edward Butler
Prescription Drugs
Committee Report: Ought to Pass with Amendment #2018-1599s, 04/26/2018
HB 1457 Relative to Drug Take-back Programs.

Rep. Victoria Sullivan
Prescription Drugs
Killed in House: MA VV 02/22/2018
HB 1457 testimony 1.17.18 FINAL.pdf (1-18)
HB 1529 Relative to Prescription Drug Rebate Amounts.

Rep. Edward Butler
Prescription Drugs
Killed in House: MA VV 03/06/2018
HB 1741 (new Title) Relative to A Definition Of "contracted Copayment" For Purposes Of The Managed Care Law.

Rep. Edward Butler
Prescription Drugs
Sen. Sanborn Moved Laid on Table, MA, VV; 04/05/2018 Pending Motion Ought to Pass; 04/05/2018
HB 1747 Relative to Packaging Of Certain Controlled Drugs.

Rep. Vincent Paul Migliore
Prescription Drugs
Killed in House: MA VV 02/08/2018
HB 1780 Prohibiting Price Gouging By Certain Prescription Drug Companies.

Rep. Rebecca McBeath
Prescription Drugs
Killed in House: MA VV 02/22/2018
HB 1791 Allowing Pharmacists to Disclose Information Relative to Lower Cost Drugs Under The Managed Care Law.

Rep. Edward Butler
Prescription Drugs
Committee Report: Ought to Pass with Amendment #2018-1637s, 04/26/2018; Vote 5-0; CC
SB 154 (2017) Making Oral Contraceptives Available Without A Prescription.

Sen. Andy Sanborn
Prescription Drugs
Refer to Interim Study, MA, VV; 01/03/2018
SB 332 Relative to Medication Synchronization.

Sen. James Gray
Prescription Drugs
Passed House: MA VV 04/19/2018
SB 350 Relative to Biological Products Dispensed By Pharmacists.

Sen. Daniel Innis
Prescription Drugs
Committee Report: Refer for Interim Study for 04/26/2018 (Vote 16-7; RC); minority recommends Ought to Pass with Amendment #2018-1523h
SB 376 Relative to The Sale Of Certain Cold Medications.

Sen. Sharon Carson
Prescription Drugs
Committee Report: Ought to Pass for 04/26/2018 (Vote 20-0; CC)
SB 481 Establishing A Committee to Study The Impact Of Pharmacy Benefit Manager Operations On Cost, Administration, and Distribution Of Prescription Drugs.

Sen. Donna Soucy
Prescription Drugs
Committee Report: Ought to Pass for 04/26/2018 (Vote 16-4; RC)
SB 483 Relative to Procedures For Dispensing Controlled Drugs.

Sen. Martha Fuller Clark
Prescription Drugs
Committee Report: Refer for Interim Study for 04/26/2018 (Vote 23-0; CC)
SB 486 Establishing A Commission to Study Enhancing The Prescription Drug Donation Program.

Sen. Dan Feltes
Prescription Drugs
Committee Report: Ought to Pass for 04/26/2018 (Vote 18-2; CC)
SB 486_2.6.18_FINAL.pdf (2-7)
SB 547 Relative to Unused Prescription Drugs.

Sen. Daniel Innis
Prescription Drugs
Refer to Interim Study, MA, VV; 02/22/2018
SB 573 Relative to The Controlled Drug Prescription Health and Safety Program and Making An Appropriation Therefor.

Sen. Jeb Bradley
Prescription Drugs
Committee Report: Ought to Pass for 04/26/2018 (Vote 26-0; RC)
SB 581 (new Title) Relative to Compounding Of Drugs.

Work Session: Tue 4/24/18 12:50 PM in LOB 308
Sen. Andy Sanborn
Prescription Drugs
Subcommittee Work Session: 04/24/2018 12:50 PM LOB 308